GlassScriptPhysician profile
Bobby A Wrights
NPI 1700814050
$89,458.07
in general payments reported to CMS, 2019-2025
52 companies · $828 in 2025
The $828 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $16K · 2021: $19K · 2022: $31K · 2023: $8,543 · 2024: $393 · 2025: $828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,354 · Food and Beverage: $3,345 · Education: $64.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,353.75 |
| Food and Beverage | $3,344.74 |
| Education | $64.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $40,411.22 | 2019-2023 | Ozempic, Rybelsus, Wegovy |
| Janssen Pharmaceuticals, INC | $38,047.89 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $1,679.41 | 2019-2025 | Farxiga, Breztri |
| Abbvie INC. | $1,328.86 | 2020-2025 | Linzess, Vraylar, Viberzi |
| Novartis Pharmaceuticals Corporation | $1,233.42 | 2019-2025 | |
| Amgen INC. | $633.50 | 2019-2025 | Repatha, Otezla, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $572.04 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $566.44 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $498.04 | 2019-2022 | |
| Organogenesis INC. | $431.30 | 2019-2025 | Apligraf, Puraply Wound Matrix, Puraply Antimicrobial |
| Glaxosmithkline, LLC. | $413.21 | 2020-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Janssen Scientific Affairs, LLC | $412.92 | 2022-2023 | Xarelto |
| Smith+Nephew, INC. | $334.08 | 2019-2025 | Collagenase Santyl, Renasys Touch, Regranex |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $333.88 | 2019-2024 | Xifaxan, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $283.66 | 2019-2023 | Cuvitru |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $251.15 | 2019-2025 | |
| Daiichi Sankyo INC. | $201.57 | 2019-2024 | Injectafer |
| Merck Sharp & Dohme LLC | $173.13 | 2019-2023 | Verquvo |
| Astellas Pharma US INC | $170.63 | 2019 | |
| Lilly USA, LLC | $151.28 | 2019-2023 | Mounjaro, Jardiance, Emgality |
| Melinta Therapeutics, LLC | $148.11 | 2019-2022 | |
| Allergan, INC. | $142.19 | 2019-2021 | |
| Abbott Laboratories | $91.21 | 2021-2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Exact Sciences Corporation | $79.86 | 2023-2025 | Cologuard Collection Kit |
| Tactile Systems Technology INC | $78.16 | 2019-2025 | Flexitouch Plus, Nimbl |
| Polarityte, INC. | $74.39 | 2019 | |
| Genzyme Corporation | $70.00 | 2019 | |
| Corcept Therapeutics | $65.64 | 2021-2025 | Korlym |
| Bsn Medical INC | $58.03 | 2024-2025 | |
| Baxter Healthcare | $45.32 | 2019 | |
| Kci USA, INC. | $42.30 | 2021 | |
| Hydrofera LLC | $39.89 | 2022 | |
| Idorsia Pharmaceuticals US INC | $36.98 | 2022-2023 | Quviviq |
| Dexcom, INC. | $36.11 | 2021-2025 | Dexcom G6 Transmitter |
| Biohaven Pharmaceuticals, INC. | $35.39 | 2021 | |
| Aimmune Therapeutics, INC. | $28.12 | 2021 | |
| Paratek Pharmaceuticals, INC. | $25.16 | 2022-2023 | Nuzyra |
| Amarin Pharma, INC. | $22.60 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $22.44 | 2023 | Dupixent |
| Ardelyx, INC. | $18.84 | 2024 | Ibsrela |
| Cardiovascular Systems INC. | $18.68 | 2019 | |
| Sanofi Pasteur INC. | $16.61 | 2025 | |
| Genentech USA, INC. | $16.16 | 2021 | |
| Ibsa Pharma INC. | $15.89 | 2023 | Tirosint, Licart |
| Phathom Pharmaceuticals, INC. | $14.25 | 2025 | Voquezna |
| Horizon Therapeutics Plc | $14.10 | 2020 | |
| Janssen Biotech, INC. | $13.96 | 2021 | |
| Ironwood Pharmaceuticals, INC | $12.51 | 2019 | |
| Mylan Specialty L.P. | $12.50 | 2020 | |
| Eisai INC. | $11.98 | 2020 | |
| Mckesson Patient Care Solutions INC. | $11.55 | 2019 | |
| Misonix INC | $11.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bobby Wrights listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.